2025
Conversion Therapy Exposure and Elevated Cardiovascular Disease Risk
Gibb J, Schrock J, Smith M, D’Aquila R, McDade T, Mustanski B. Conversion Therapy Exposure and Elevated Cardiovascular Disease Risk. JAMA Network Open 2025, 8: e258745. PMID: 40327341, DOI: 10.1001/jamanetworkopen.2025.8745.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlood PressureCardiovascular DiseasesChicagoCohort StudiesCross-Sectional StudiesFemaleHeart Disease Risk FactorsHumansMaleSexual and Gender MinoritiesYoung AdultConceptsHigh blood pressureSystolic blood pressureDiastolic blood pressureSelf-reported high blood pressureCohort studyCardiovascular health dataCardiovascular health indicatorsSelf-reported hypertensionSGM health disparitiesMental health impactsCardiovascular health consequencesCardiovascular disease riskBlood pressureElevated diastolic blood pressureHealth disparitiesCare approachElevated systolic blood pressureHealth indicatorsMain OutcomesIncreased DBPBehavioral covariatesHealth dataSGM individualsDisease riskHealth consequencesThe burden of cardiovascular disease in Latin America and the Caribbean, 1990-2019: An analysis of the global burden of disease study
Alhuneafat L, Al Ta'ani O, Arriola-Montenegro J, Al-Ajloun Y, Naser A, Chaponan-Lavalle A, Ordaya-Gonzales K, Pertuz G, Maaita A, Jabri A, Altibi A, Al-Abdouh A, Van't Hof J, Gutierrez Bernal A. The burden of cardiovascular disease in Latin America and the Caribbean, 1990-2019: An analysis of the global burden of disease study. International Journal Of Cardiology 2025, 428: 133143. PMID: 40064205, DOI: 10.1016/j.ijcard.2025.133143.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCardiovascular DiseasesCaribbean RegionCost of IllnessFemaleGlobal Burden of DiseaseHumansIncidenceLatin AmericaMaleMiddle AgedPrevalenceRisk FactorsConceptsDisability-adjusted life yearsGlobal Burden of DiseaseBurden of cardiovascular diseaseCardiovascular diseaseRisk factorsMortality-to-incidence ratioGlobal burdenIschemic heart diseaseAge-standardized disability-adjusted life yearsGlobal Burden of Disease StudyDisability-adjusted life year ratesBurden of Disease StudyAge-standardized prevalenceComparative risk assessment frameworkCardiovascular disease prevalenceCardiovascular disease burdenBurden of diseaseLeading risk factorHeart diseaseTailored interventionsCountry-specific variationsElevated BMIRate of strokeHealthcare infrastructureSocio-economic factorsIdentification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities
Loesch D, Garg M, Matelska D, Vitsios D, Jiang X, Ritchie S, Sun B, Runz H, Whelan C, Holman R, Mentz R, Moura F, Wiviott S, Sabatine M, Udler M, Gause-Nilsson I, Petrovski S, Oscarsson J, Nag A, Paul D, Inouye M. Identification of plasma proteomic markers underlying polygenic risk of type 2 diabetes and related comorbidities. Nature Communications 2025, 16: 2124. PMID: 40032831, PMCID: PMC11876343, DOI: 10.1038/s41467-025-56695-z.Peer-Reviewed Original ResearchMeSH KeywordsBiomarkersCardiovascular DiseasesComorbidityDiabetes Mellitus, Type 2Extracellular Matrix ProteinsFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansInsulin-Like Growth Factor Binding Protein 2MaleMiddle AgedMultifactorial InheritanceProteomicsRisk FactorsUnited KingdomConceptsPolygenic scoresNon-coding variantsEtiology of type 2 diabetesMolecular dataVariant effectsPathway enrichmentPlasma proteomic markersPotential therapeutic targetType 2 diabetesProteinDisease biologyPolygenic riskUK BiobankProteomic markersTherapeutic targetPathwayCirculating proteinsGenomeRisk of type 2 diabetesCardiometabolic scoreBiologyInteractive portalVariantsEnrichmentDiabetes comorbiditiesOptimizing Psychological Health Across the Perinatal Period: An Update on Maternal Cardiovascular Health: A Scientific Statement From the American Heart Association.
Sharma G, Gaffey A, Hameed A, Kasparian N, Mauricio R, Marsh E, Beck D, Skowronski J, Wolfe D, Levine G. Optimizing Psychological Health Across the Perinatal Period: An Update on Maternal Cardiovascular Health: A Scientific Statement From the American Heart Association. Journal Of The American Heart Association 2025, 14: e041369. PMID: 39996493, DOI: 10.1161/jaha.125.041369.Peer-Reviewed Original ResearchMeSH KeywordsAmerican Heart AssociationCardiovascular DiseasesFemaleHumansMaternal HealthMental HealthPerinatal CarePregnancyPregnancy ComplicationsRisk FactorsUnited StatesConceptsMaternal cardiovascular healthPsychological healthCardiovascular healthAmerican Heart AssociationPerinatal periodCare delivery modelsMaternal psychological healthScientific statementPsychological health carePostpartum follow-upHeart AssociationPsychological health conditionsAssociated with adverse pregnancy outcomesCardiovascular outcomesMaternal mortalityAdverse pregnancy outcomesHealth careDelivery modelsHealth conditionsLong-term cardiovascular outcomesHealthStakeholder partnersOffspring neurodevelopmentPregnancy outcomesCareSuppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases
Rubinelli L, Manzo O, Sungho J, Del Gaudio I, Bareja R, Marino A, Palikhe S, Di Mauro V, Bucci M, Falcone D, Elemento O, Ersoy B, Diano S, Sasset L, Di Lorenzo A. Suppression of endothelial ceramide de novo biosynthesis by Nogo-B contributes to cardiometabolic diseases. Nature Communications 2025, 16: 1968. PMID: 40000621, PMCID: PMC11862206, DOI: 10.1038/s41467-025-56869-9.Peer-Reviewed Original ResearchConceptsNogo-BEndothelial dysfunctionHFD miceCardiometabolic diseasesSphingolipid signalingDevelopment of therapeutic strategiesBioactive sphingolipidsCeramide degradationSphingosine-1-phosphateHepatic glucose productionIn vivo evidenceEndothelial cellsEndothelial specific deletionCeramideBiosynthesisHigh-fat dietPathological implicationsSphingolipidsGlucose productionHFDIn vivoMale miceMetabolic dysfunctionTherapeutic strategiesMetabolic disordersIntegration and Potential Applications of Cardiovascular Computed Tomography in Cardio-Oncology
Erbay M, Manubolu V, Stein-Merlob A, Ferencik M, Mamas M, Lopez-Mattei J, Baldassarre L, Budoff M, Yang E. Integration and Potential Applications of Cardiovascular Computed Tomography in Cardio-Oncology. Current Cardiology Reports 2025, 27: 51. PMID: 39932640, PMCID: PMC11814013, DOI: 10.1007/s11886-025-02206-x.Peer-Reviewed Original ResearchMeSH KeywordsCardiovascular DiseasesCoronary Artery DiseaseHumansNeoplasmsRisk FactorsTomography, X-Ray ComputedConceptsRadiation-induced cardiovascular diseaseCoronary artery diseaseCardiovascular diseaseCardiac massComputed tomographyArtery diseaseChest CT scans of patientsCT scans of patientsIncreased risk of CVDInvasive coronary angiographyRisk of cardiovascular diseaseRisk of complicationsScans of patientsCardiovascular computed tomographySeverity of cardiovascular diseaseNon-invasive imaging toolMonitoring of disease progressionManifestations of diseaseAsymptomatic patientsCardiac deteriorationIschemia evaluationCoronary angiographyPericardial diseaseCardiac changesRisk stratificationPower and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies
Owen M, Curran G, Smith J, Tedla Y, Cheng C, Spiegelman D. Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies. Statistics In Medicine 2025, 44: e70015. PMID: 39930740, DOI: 10.1002/sim.70015.Peer-Reviewed Original ResearchMeSH KeywordsCardiovascular DiseasesCluster AnalysisHumansModels, StatisticalRandomized Controlled Trials as TopicResearch DesignSample SizeConceptsHybrid type 2 effectiveness-implementation studySample size calculationCluster randomized trialCluster randomized designSize calculationImplementation research outcomesReduce cardiovascular diseaseIssue of multiple testingEffective outcomesImplementation outcomesCommunity interventionsControl blood pressureBinary outcomesOutcomes approachLiterature searchMultiple testingCardiovascular diseaseInterventionRandomized trialsStandard statistical methodsBlood pressureOutcomesType 2 studiesDiagnosis of cancer therapy-related cardiovascular toxicities: A multimodality integrative approach and future developments
Travers S, Alexandre J, Baldassarre L, Salem J, Mirabel M. Diagnosis of cancer therapy-related cardiovascular toxicities: A multimodality integrative approach and future developments. Archives Of Cardiovascular Diseases 2025, 118: 185-198. PMID: 39947997, DOI: 10.1016/j.acvd.2024.12.012.Peer-Reviewed Original ResearchConceptsCardio-oncologyCardiovascular toxicityCardiovascular imagingMultimodality cardiovascular imagingCancer risk factorsIncrease diagnostic accuracyPrognostic stratificationNatriuretic peptideSerum biomarkersTherapy schemesDiagnostic accuracyCancer therapyRhythm disordersRisk factorsCardiovascular diseaseBiomarkersMultimodal integrated approachCancerOmics approachesToxicityRhythmTherapyTroponinSerumDiagnosisChronic kidney disease
Romagnani P, Agarwal R, Chan J, Levin A, Kalyesubula R, Karam S, Nangaku M, Rodríguez-Iturbe B, Anders H. Chronic kidney disease. Nature Reviews Disease Primers 2025, 11: 8. PMID: 39885176, DOI: 10.1038/s41572-024-00589-9.Peer-Reviewed Original ResearchMeSH KeywordsCardiovascular DiseasesDisease ProgressionHumansHypertensionQuality of LifeRenal Insufficiency, ChronicRenin-Angiotensin SystemRisk FactorsConceptsChronic kidney diseaseKidney functionPresence of concomitant risk factorsRisk factorsSodium-glucose transporter 2Abnormalities of kidney functionConcomitant risk factorsManagement of patientsExcretory kidney functionKidney replacement therapyRenin-angiotensin systemModifiable risk factorsAssociated with accelerated cardiovascular diseaseSecondary hyperparathyroidismSequential injuryPersistent abnormalitiesReplacement therapySodium-glucoseCardiovascular morbidityMetabolic acidosisSevere infectionsCKD progressionKidney diseaseKidney failureTransporter 2Assessing cardiovascular disease risk and social determinants of health: A comparative analysis of five risk estimation instruments using data from the Eastern Caribbean Health Outcomes Research Network
Schwartz J, Howitt C, Raman S, Nair S, Hassan S, Oladele C, Hambleton I, Sarpong D, Adams O, Maharaj R, Nazario C, Nunez M, Nunez-Smith M. Assessing cardiovascular disease risk and social determinants of health: A comparative analysis of five risk estimation instruments using data from the Eastern Caribbean Health Outcomes Research Network. PLOS ONE 2025, 20: e0316577. PMID: 39854547, PMCID: PMC11760610, DOI: 10.1371/journal.pone.0316577.Peer-Reviewed Original ResearchConceptsCardiovascular disease riskSocial determinants of healthDeterminants of healthSocial determinantsRisk estimation toolsCardiovascular diseaseEstimate 10-year CVD riskCVD riskEastern Caribbean Health Outcomes Research NetworkCardiovascular disease risk estimatesHigh riskHigher level of educationHistory of cardiovascular diseaseHigher CVD riskMultivariate logistic regression modelEthnically diverse populationsResource-constrained settingsLogistic regression modelsNon-professional occupationsSDoH variablesLevel of educationSDoHPerceived social statusRisk toolFraminghamDeterminants of Racial and Ethnic Differences in Maternal Cardiovascular Health in Early Pregnancy
Cameron N, Huang X, Petito L, Ning H, Shah N, Yee L, Perak A, Haas D, Mercer B, Parry S, Saade G, Silver R, Simhan H, Reddy U, Varagic J, Licon E, Greenland P, Lloyd-Jones D, Kershaw K, Grobman W, Khan S. Determinants of Racial and Ethnic Differences in Maternal Cardiovascular Health in Early Pregnancy. Circulation Cardiovascular Quality And Outcomes 2025, 18: e011217. PMID: 39807595, PMCID: PMC11919558, DOI: 10.1161/circoutcomes.124.011217.Peer-Reviewed Original ResearchMeSH KeywordsAdultBlack or African AmericanCardiovascular DiseasesFemaleHealth Status DisparitiesHispanic or LatinoHumansMaternal HealthPregnancyPregnancy Trimester, FirstRace FactorsResidence CharacteristicsRisk AssessmentRisk FactorsSocial Determinants of HealthSocioeconomic FactorsUnited StatesWhiteWhite PeopleYoung AdultConceptsNon-Hispanic blacksNon-Hispanic whitesNeighborhood-level factorsNon-Hispanic black groupsCardiovascular health scoreMaternal cardiovascular healthNon-Hispanic White groupCardiovascular healthEthnic differencesLife's Essential 8 scoreSuboptimal cardiovascular healthContributions of individual-Public health effortsYears of educationNulliparous individualsReduce disparitiesHealth effortsProportion of differencesCohort studyOffspring outcomesEducational attainmentIndividual-Higher scoresAssess factorsSingleton pregnanciesMortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study
Njei B, Mezzacappa C, John B, Serper M, Kaplan D, Taddei T, Mahmud N. Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study. Digestive Diseases And Sciences 2025, 70: 802-813. PMID: 39779587, PMCID: PMC11839701, DOI: 10.1007/s10620-024-08764-4.Peer-Reviewed Original ResearchConceptsNon-lean individualsAll-cause mortalityMajor adverse cardiovascular eventsIncreased risk of all-cause mortalityRisk of all-cause mortalityVeterans Health AdministrationRisk of hepatic decompensationPrevalence of diabetesRisk of cardiovascular mortalityHepatic decompensationHigher mortality riskCardiovascular-related mortalityCox proportional hazards modelsCohort study of patientsCardiovascular outcomesIncident major adverse cardiovascular eventsRetrospective cohort study of patientsProportional hazards modelNon-HispanicRetrospective cohort studyCompeting risk regressionHealth AdministrationMultivariate Cox proportional hazards modelLean individualsAssessed associationsLiver Fibrosis and Cardiovascular Events
Nso N, Bookani K, Trimingham M, Orji R, Njei B, Balasubramanian S, Pursnani A. Liver Fibrosis and Cardiovascular Events. Southern Medical Journal 2025, 118: 19-25. PMID: 39753232, DOI: 10.14423/smj.0000000000001769.Peer-Reviewed Original ResearchMeSH KeywordsCardiovascular DiseasesHumansLiver CirrhosisNon-alcoholic Fatty Liver DiseaseRisk FactorsSeverity of Illness IndexConceptsLiver fibrosis scoresNonalcoholic fatty liver diseaseRisk of cardiovascular eventsNAFLD fibrosis scoreCardiovascular eventsAll-cause mortalityFibrosis scoreLiver fibrosisSystematic reviewFibrosis-4Noninvasive liver fibrosis scoresLiver diseaseCardiovascular mortalityHigh risk of cardiovascular eventsNonalcoholic fatty liver disease fibrosis scoreRelevant prospective studiesSeverity of liver fibrosisNational Institutes of Health toolCardiovascular diseaseHigher liver fibrosis scoresSpectrum of cardiovascular diseasesFibrosis-4 scoreSeverity of fibrosisCardiovascular event occurrenceChronic liver disease
2024
Identification of Gender Differences in Acute Myocardial Infarction Presentation and Management at Aga Khan University Hospital-Pakistan: Natural Language Processing Application in a Dataset of Patients With Cardiovascular Disease
Ngaruiya C, Samad Z, Tajuddin S, Nasim Z, Leff R, Farhad A, Pires K, Khan M, Hartz L, Safdar B. Identification of Gender Differences in Acute Myocardial Infarction Presentation and Management at Aga Khan University Hospital-Pakistan: Natural Language Processing Application in a Dataset of Patients With Cardiovascular Disease. JMIR Formative Research 2024, 8: e42774. PMID: 39705071, PMCID: PMC11699486, DOI: 10.2196/42774.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedCardiovascular DiseasesFemaleHospitals, UniversityHumansMaleMiddle AgedMyocardial InfarctionNatural Language ProcessingPakistanSex FactorsConceptsAMI symptomsAcute myocardial infarctionNatural language processingTertiary care hospitalAssess gender differencesCare hospitalAcute myocardial infarction presentationsMiddle-income countriesIdentification of gender differencesPrimary discharge diagnosisGender differencesMyocardial infarction presentationManagement of patientsNatural language processing applicationsDisproportionate burdenFuzzy matching techniqueHigher oddsLanguage processing applicationsDischarge summariesMedication prescriptionsClinical priorityIschemic heart diseaseDischarge diagnosisLMICsPrescribed statinsType 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
Moura F, Kamanu F, Wiviott S, Giugliano R, Udler M, Florez J, Ellinor P, Sabatine M, Ruff C, Marston N. Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers. Diabetes Obesity And Metabolism 2024, 27: 1287-1295. PMID: 39696834, DOI: 10.1111/dom.16123.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntibodies, Monoclonal, HumanizedAnticholesteremic AgentsCardiovascular DiseasesCholesterol, LDLDiabetes Mellitus, Type 2FemaleGenetic Predisposition to DiseaseGlycated HemoglobinHumansHydroxymethylglutaryl-CoA Reductase InhibitorsIncidenceMaleMiddle AgedMultifactorial InheritancePCSK9 InhibitorsPolymorphism, Single NucleotideProprotein Convertase 9Risk FactorsConceptsT2D polygenic scoreBody mass indexProprotein convertase subtilisin/kexin type 9Incident diabetesPolygenic scoresGenetic riskIncident T2DHazard ratioStable atherosclerotic cardiovascular diseaseProprotein convertase subtilisin/kexin type 9 inhibitionYears of median follow-upFurther Cardiovascular Outcomes ResearchRisk factorsMean body mass indexCases of incident diabetesMedian follow-upLower body mass indexPredictor of incident diabetesEffects of evolocumabGenetic risk categoriesLDL cholesterol levelsT2D genetic riskDiabetes risk factorsType 2 diabetes genetic riskAtherosclerotic cardiovascular diseasePathways From Socioeconomic Factors to Major Cardiovascular Events Among Postmenopausal Veteran and Nonveteran Women: Findings From the Women's Health Initiative.
Beydoun H, Beydoun M, Kinney R, Liu S, Yu R, Allison M, Wallace R, Xiao Q, Liu L, Gradidge P, Jung S, Tindle H, Follis S, Brunner R, Tsai J. Pathways From Socioeconomic Factors to Major Cardiovascular Events Among Postmenopausal Veteran and Nonveteran Women: Findings From the Women's Health Initiative. Journal Of The American Heart Association 2024, 13: e037253. PMID: 39673348, PMCID: PMC11935538, DOI: 10.1161/jaha.124.037253.Peer-Reviewed Original ResearchConceptsSelf-rated healthCardiovascular disease eventsCardiometabolic risk factorsNeighborhood socioeconomic statusBody mass indexSocioeconomic statusMass indexCardiovascular diseaseRisk factorsIndicators of socioeconomic statusEffect of socioeconomic statusHousehold incomeSocioeconomic status characteristicsWomen's Health InitiativeGeneralized structural equation modelHealth characteristicsHealth initiativesPostmenopausal womenLower educationProvider accessVeteran statusMarital statusNonveteran counterpartsSocioeconomic factorsBiopsychosocial mechanismsAdverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors
Kwan J, Shen M, Akhlaghi N, Hu J, Mora R, Cross J, Jiang M, Mankbadi M, Wang P, Zaman S, Lee S, Im Y, Feher A, Liu Y, S. S, Tao W, Wei W, Baldassarre L. Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors. PLOS ONE 2024, 19: e0314555. PMID: 39621799, PMCID: PMC11611253, DOI: 10.1371/journal.pone.0314555.Peer-Reviewed Original ResearchMeSH KeywordsAgedCardiovascular DiseasesEchocardiographyFemaleHumansImmune Checkpoint InhibitorsMagnetic Resonance ImagingMaleMiddle AgedNeoplasmsRetrospective StudiesRisk FactorsConceptsAdverse cardiovascular eventsICI therapyCardiac magnetic resonanceIncreased risk of mortalityICI initiationIncreased riskRisk of mortalityCentral nervous systemVentricular dysfunctionCancer patients treated with ICIsCardiovascular eventsLeft ventricular late gadolinium enhancementMortality benefitCardiovascular riskAbnormal left ventricular ejection fractionPatients treated with ICIsLeft ventricular ejection fractionCentral nervous system malignanciesRisk of adverse cardiovascular eventsImmune checkpoint inhibitorsRight ventricular dysfunctionGlobal longitudinal strainVentricular ejection fractionLeft ventricular dysfunctionMultimodality cardiac imagingArtificial Intelligence in Cardiovascular Clinical Trials
Cunningham J, Abraham W, Bhatt A, Dunn J, Felker G, Jain S, Lindsell C, Mace M, Martyn T, Shah R, Tison G, Fakhouri T, Psotka M, Krumholz H, Fiuzat M, O’Connor C, Solomon S, Collaboratory H. Artificial Intelligence in Cardiovascular Clinical Trials. Journal Of The American College Of Cardiology 2024, 84: 2051-2062. PMID: 39505413, DOI: 10.1016/j.jacc.2024.08.069.Peer-Reviewed Original ResearchMeSH KeywordsArtificial IntelligenceCardiovascular DiseasesClinical Trials as TopicHumansRandomized Controlled Trials as TopicConceptsArtificial intelligenceIntegrate AIPatient privacyClinical trialsRandomized clinical trialsClinical event outcomesCardiovascular clinical trialsIntelligenceInaccurate resultsRandomized trialsInterpreting imagesCardiovascular therapyMedical decision makingDecision makingGold standardValidity of trial resultsClinical trial operationsPrivacyLife's Essential 8 and Poor Brain Health Outcomes in Middle-Aged Adults
Clocchiatti-Tuozzo S, Rivier C, Renedo D, Huo S, Hawkes M, de Havenon A, Schwamm L, Sheth K, Gill T, Falcone G. Life's Essential 8 and Poor Brain Health Outcomes in Middle-Aged Adults. Neurology 2024, 103: e209990. PMID: 39442069, PMCID: PMC11498939, DOI: 10.1212/wnl.0000000000209990.Peer-Reviewed Original ResearchMeSH KeywordsAgedBrainCardiovascular DiseasesDementiaDepressionFemaleHeart Disease Risk FactorsHumansMaleMiddle AgedProspective StudiesRisk FactorsStrokeUnited KingdomUnited StatesConceptsLife's Essential 8Poor cardiovascular healthCardiovascular healthBrain healthLife's Essential 8 scoreUnadjusted riskEssential 8Determinants of cardiovascular healthUK Biobank (UKBCardiovascular health profileModifiable cardiovascular risk factorsBrain health outcomesRisk factorsComposite outcomePublic health constructsPopulation studiesMiddle-aged adultsCox modelLate-life depressionCox proportional hazards modelsBrain health benefitsMultivariate Cox modelCardiovascular risk factorsFollow-up timeAoU participantsLong-Term Exposure to Arsenic in Community Water Supplies and Risk of Cardiovascular Disease among Women in the California Teachers Study
Medgyesi D, Bangia K, Spielfogel E, Fisher J, Madrigal J, Jones R, Ward M, Lacey J, Sanchez T. Long-Term Exposure to Arsenic in Community Water Supplies and Risk of Cardiovascular Disease among Women in the California Teachers Study. Environmental Health Perspectives 2024, 132: 107006. PMID: 39440943, PMCID: PMC11498017, DOI: 10.1289/ehp14410.Peer-Reviewed Original ResearchConceptsBody mass indexIschemic heart diseaseHazard ratioCardiovascular diseaseHealth care administrative recordsSmoking statusCalifornia Teachers Study cohortIschemic heart disease casesRisk of ischemic heart diseaseParticipant's residential addressNeighborhood socioeconomic statusCalifornia Teachers StudyCardiovascular disease casesCases of ischemic heart diseaseCardiovascular disease riskRisk of cardiovascular diseaseIncreased cardiovascular disease riskResidential addressesFollow-upSocioeconomic statusYears of ageStratified analysisBaseline ageTeachers StudyCommunity water supplies
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply